This American Express Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Warren Buffett's Successor, Greg Abel, Has Over 45% of Berkshire Hathaway's $356 Billion Portfolio Invested in 3 Undeniable Winners

Greg Abel, Warren Buffett's successor as CEO of Berkshire Hathaway, has maintained the company's portfolio concentration strategy with over 45% ($160.6 billion) of invested assets in three major holdings: Apple ($76.73 billion), American Express ($46.72 billion), and Alphabet ($37.17 billion). While Buffett sold 75% of Apple before retirement, Abel views it as a long-term compounder. Abel has significantly increased Berkshire's Alphabet stake, tripling it in Q1 and adding $17 billion in Q2, attracted by Google's search dominance and AI ambitions in Google Cloud.

American Express Prelim U.S. Consumer Card 30 Days Past Due Rate 1.2% As Of Sept 30, 2026; Prelim U.S. Consumer Card Net Write-Off Rate (Principal Only) 1.5% As Of Sept 30, 2026; Prelim U.S. Small Business Card Net Write-Off Rate (Principal Only) 2.1% As Of Sept 30, 2026; Prelim U.S. Small Business Card 30 Days Past Due As A % Of Total 1.4% As Of Sept 30, 2026

8-K filing — AMERICAN EXPRESS CO (AXP)

Filed: 2026-10-15 AccNo: 0000004962-26-000383 Size: 268 KB Item 7.01: Regulation FD Disclosure

History Says Berkshire Hathaway Stock Holds Up When the Market Falls: It Beat the S&P 500 in 11 of 13 Down Years

Berkshire Hathaway has outperformed the S&P 500 in 11 of 13 down market years since 1965, demonstrating resilience during market downturns. The company's diversified business portfolio, substantial cash reserves ($365.5 billion), and disciplined investment approach provide protection against market volatility, though it has underperformed in 2026 with only 3% gains versus the S&P 500's 14% rise.

Cantor Fitzgerald Maintains Overweight on Duos Technologies Group, Lowers Price Target to $24

Cantor Fitzgerald analyst Brett Knoblauch maintains Duos Technologies Group (NASDAQ:DUOT) with a Overweight and lowers the price target from $27 to $24.

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).